Health Care Technology
Company Overview of MedAvante, Inc.
MedAvante, Inc. provides psychiatric and neurocognition rating and monitoring services to the pharmaceutical, biotech, and medical device industries in the United States and internationally. The company offers centralized assessments to enhance assay sensitivity in clinical drug trials of treatments for central nervous system disorders; Virgil, an investigative study platform that provides trial sponsors with the ability to centralize and standardize study assessments with their own network of trusted investigators; and remotely assesses and scores subjects at local investigative sites. The company offers neurocognition study instrument scoring based on recorded assessments administered by l...
100 American Metro Boulevard
Hamilton, NJ 08619
Founded in 2002
Key Executives for MedAvante, Inc.
Co-Founder and Chief Executive Officer
Senior Vice President of Global Operations
Senior Vice President of Global Science
Compensation as of Fiscal Year 2015.
MedAvante, Inc. Key Developments
Cerecor Inc. Selects MedAvante, Inc.'s MedAvante Central Ratings For Investigational MDD Study
Dec 2 13
MedAvante, Inc. announced that biopharmaceutical company Cerecor Inc. will use MedAvante Central Ratings in the phase 2 clinical study of CERC-301, an investigational drug intended for the adjunctive treatment of subjects with major depressive disorder (MDD) who have not adequately responded to their current therapy and report recent suicidal ideation.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries